[O5] Involuntary movement

[O-029] The efficacy of GPi—DBS in two KMT2B mutation cases using the quantitative evaluation system

Yohane Miyata^1,2, HIROTAKA YOSHIDA³, TAKERU HONDA³, SATOKO KUMADA¹, HIDEAKI MASHIMO¹, HIROYA NISHIDA¹, IKUKO SHIRAI¹, FUSAKO YOKOCHI⁸, SHINJI KAKEI³, KOHEI HAMANAKA⁴, SATOKO MIYATAKE⁴, Naomichi Matsumoto⁴, AYAKO HATTORI⁵, TOSHITAKA KAWARAI⁶, MAKOTO TANIGUCHI⁷ (1.Department of pediatric neurology, Tokyo Metropolitan Neurological Hospital, Tokyo, Japan, 2.Department of Pediatrics, Kyorin University School of Medicine, Tokyo, Japan, 3.Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan, 4.Department of Human Genetics, Yokohama City University Graduate School of Me dicine, Kanagawa, Japan)